Clinical Trials Logo

Clinical Trial Summary

The ability to explain bleeding or clotting complications in patients treated with rivaroxaban remains challenging. In addition, there is limited data on how coagulation tests perform in patients treated with therapeutic doses of rivaroxaban. Predicted responses of coagulation tests to therapeutic doses of rivaroxaban may be helpful in better understanding abnormal responses to rivaroxaban. The purpose of the study is to define a therapeutic reference range for peak and trough coagulation tests in patients taking FDA approved doses of rivaroxaban and to determine which tests may be most clinically useful for monitoring rivaroxaban.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01743898
Study type Observational
Source University of North Carolina, Chapel Hill
Contact
Status Completed
Phase N/A
Start date October 2012
Completion date August 2014

See also
  Status Clinical Trial Phase
Completed NCT03365999 - Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement. Phase 2
Not yet recruiting NCT06329921 - Inpatient Monitoring of Unfractionated Heparin N/A
Recruiting NCT02445690 - Thrombin Generation in Crohn's Disease N/A
Recruiting NCT05095844 - National Vaccine Adverse Event Reporting Survey and Etiology
Completed NCT03280368 - Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
Recruiting NCT04650529 - Gyeongsang National University Hospital Registry
Recruiting NCT04319627 - Statins for Venous Event Reduction in Patients With Venous Thromboembolism Phase 3
Completed NCT02744092 - Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer N/A
Not yet recruiting NCT03217799 - Noninvasive Measurement of Blood Coagulation N/A
Completed NCT03274674 - Use of Injectable-platelet-rich-fibrin (I-PRF) to Thicken Gingival Phenotype N/A
Completed NCT02984384 - PREVENTion of Clot in Orthopaedic Trauma Phase 3